Immunological aspects of endometriosis: A review

Annals of Translational Medicine

Volumn 3, Issue 11, 2015, Pages

  Králíčková, Milena ^a,b   Vetvicka, Vaclav ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c University of Louisville School of Medicine   (United States)

Author keywords

Cytokines; Endometriosis; Immunology; Lymphocytes

Indexed keywords

EID: 85015483564     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.3978/j.issn.2305-5839.2015.06.08     Document Type: Review

References (46)

1. Von Rokitansky C. Uber Uterusdrusen-Neuerbildung in Uterus and Ovarilsarcomen, Z Gesselschaft Aerzte Wien 1860;37:577-93.
2. Wood DH, Yochmowitz MG, Salmon YL, et al. Proton irradiation and endometriosis. Aviat Space Environ Med 1983;54:718-24.
3. Steele RW, Dmowski WP, Marmer DJ. Immunologic aspects of human endometriosis. Am J Reprod Immunol 1984;6:33-6.
4. Kanzaki H, Wang HS, Kariya M, et al. Suppression of natural killer cell activity by sera from patients with endometriosis. Am J Obstet Gynecol 1992;167:257-61.
5. Tanaka E, Sendo F, Kawagoe S, et al. Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest 1992;34:27-30.
6. Viganò P, Somigliana E, Di Blasio AM, et al. Suppression of natural killer cell function and production of soluble ICAM-1: endometrial stroma versus melanoma. Am J Reprod Immunol 2001;46:342-8.
7. Oosterlynck DJ, Meuleman C, Waer M, et al. Immunosuppressive activity of peritoneal fluid in women with endometriosis. Obstet Gynecol 1993;82:206-12.
8. Semino C, Semino A, Pietra G, et al. Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. Fertil Steril 1995;64:909-16.
9. Osuga Y, Koga K, Hirota Y, et al. Lymphocytes in endometriosis. Am J Reprod Immunol 2011;65:1-10.
10. Hornung D, Fujii E, Lim KH, et al. Histocompatibility leukocyte antigen-G is not expressed by endometriosis or endometrial tissue. Fertil Steril 2001;75:814-7.
11. Wu MY, Yang JH, Chao KH, et al. Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis. Fertil Steril 2000;74:1187-91.
12. Chrobak A, Gmyrek GB, Sozanski R, et al. The influence of extracellular matrix proteins on T-cell proliferation and apoptosis in women with endometriosis or uterine leiomyoma. Am J Reprod Immunol 2004;51:123-9.
13. Melioli G, Semino C, Semino A, et al. Recombinant interleukin-2 corrects in vitro the immunological defect of endometriosis. Am J Reprod Immunol 1993;30:218-27.
14. Ho HN, Wu MY, Chao KH, et al. Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis. Hum Reprod 1997;12:2528-33.
15. Berbic M, Fraser IS. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol 2011;88:149-55.
16. Budiu RA, Diaconu I, Chrissluis R, et al. A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells. Dis Model Mech 2009;2:593-603.
17. Vlad AM, Diaconu I, Gantt KR. MUC1 in endometriosis and ovarian cancer. Immunol Res 2006;36:229-36.
18. Wu MH, Shoji Y, Wu MC, et al. Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol 2005;167:1061-9.
19. de Villiers WJ, Fraser IP, Gordon S. Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. Immunol Lett 1994;43:73-9.
20. Viganò P, Gaffuri B, Somigliana E, et al. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998;4:1150-6.
21. Dmowski WP, Steele RW, Baker GF. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 1981;141:377-83.
22. Maeda N, Izumiya C, Oguri H, et al. Aberrant expression of intercellular adhesion molecule-1 and killer inhibitory receptors induces immune tolerance in women with pelvic endometriosis. Fertil Steril 2002;77:679-83.
23. Capobianco A, Monno A, Cottone L, et al. Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. Am J Pathol 2011;179:2651-9.
24. Králícková M, Vetvicka V. Endometriosis and ovarian cancer. World J Clin Oncol 2014;5:800-5.
25. Pasoto SG, Abrao MS, Viana VS, et al. Endometriosis and systemic lupus erythematosus: a comparative evaluation of clinical manifestations and serological autoimmune phenomena. Am J Reprod Immunol 2005;53:85-93.
26. Matorras R, Ocerin I, Unamuno M, et al. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome. Lupus 2007;16:736-40.
27. Taylor PV, Maloney MD, Campbell JM, et al. Autoreactivity in women with endometriosis. Br J Obstet Gynaecol 1991;98:680-4.
28. Garza D, Mathur S, Dowd MM, et al. Antigenic differences between the endometrium of women with and without endometriosis. J Reprod Med 1991;36:177-82.
29. Yeaman GR, Collins JE, Lang GA. Autoantibody responses to carbohydrate epitopes in endometriosis. Ann N Y Acad Sci 2002;955:174-82; discussion 199-200, 396-406.
30. Ulukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. J Soc Gynecol Investig 2006;13:467-76.
31. Tanaka T, Umesaki N, Mizuno K, et al. Anti-endometrial IgM autoantibodies in endometriotic patients: a preliminary study. Clin Exp Obstet Gynecol 2000;27:133-7.
32. Vignali M, Infantino M, Matrone R, et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril 2002;78:665-78.
33. Nothnick WB, Curry TE, Vernon MW. Immunomodulation of rat endometriotic implant growth and protein production. Am J Reprod Immunol 1994;31:151-62.
34. Olovsson M. Immunological aspects of endometriosis: an update. Am J Reprod Immunol 2011;66 Suppl 1:101-4.
35. Suryawanshi S, Huang X, Elishaev E, et al. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2014;20:6163-74.
36. Giudice LC, Tazuke SI, Swiersz L. Status of current research on endometriosis. J Reprod Med 1998;43:252-62.
37. Iwabe T, Harada T, Tsudo T, et al. Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1998;69:924-30.
38. Bulun SE, Cheng YH, Pavone ME, et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med 2010;28:36-43.
39. Gilmore SM, Aksel S, HoffC, et al. In vitro lymphocyte activity in women with endometriosis-an altered immune response? Fertil Steril 1992;58:1148-52.
40. Antsiferova YS, Sotnikova NY, Posiseeva LV, et al. Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis. Fertil Steril 2005;84:1705-11.
41. Gmyrek GB, Sieradzka U, Goluda M, et al. Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis. Immunol Invest 2008;37:43-61.
42. Ali AF, Fateen B, Ezzet A, et al. Laparoscopic intraperitoneal injection of human interferon-α2b in the treatment of pelvic endometriosis: a new modality. Obstet Gynecol 2000;95:47S-8S.
43. D'Antonio M, Martelli F, Peano S, et al. Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats. J Reprod Immunol 2000;48:81-98.
44. Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 2002;17:426-31.
45. Kao AP, Wang KH, Long CY, et al. Interleukin-1β induces cyclooxygenase-2 expression and promotes the invasive ability of human mesenchymal stem cells derived from ovarian endometrioma. Fertil Steril 2011;96:678-84.
46. Herington JL, Bruner-Tran KL, Lucas JA, et al. Immune interactions in endometriosis. Expert Rev Clin Immunol 2011;7:611-26.